Simultaneous Cardiotoxicity and Neurotoxicity Associated with 5-fluorouracil Containing Chemotherapy: A Case Report and Literature Review
Open Access
- 9 January 2020
- journal article
- Published by Science and Education Publishing Co., Ltd. in American Journal of Medical Case Reports
- Vol. 8 (3) , 73-75
Abstract
We present a case of simultaneous cardiotoxicity and stroke-like neurotoxicity in a patient treated with FOLFOX, a 5-Fluorouracil (5-FU)-containing chemotherapy regimen. Within hours of FOLFOX infusion, the patient began to exhibit signs and symptoms of myocardial ischemia and stroke mimic. Coronary vasoconstriction and vasospasm is a known mechanism of 5-FU-induced cardiotoxicity. 5-FU-induced neurotoxicity commonly presents as encephalopathy and is likely attributable to the accumulation of ammonia, a product of 5-FU metabolism. However, our patient presented with focal neurological signs and normal levels of ammonia. This suggests that 5-FU-induced vasospasm in the coronary arteries and cerebral vasculature is a likely cause of the simultaneous cardiac and neurological events we report here which have not been reported previously. Recognition of these toxicities as complications of 5-FU chemotherapy is crucial for the proper diagnosis and treatment of patients.Keywords
This publication has 21 references indexed in Scilit:
- Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factorsCancer Treatment Reviews, 2013
- A Case of Severe Coronary Spasm Associated with 5-Fluorouracil ChemotherapyThe Korean Journal of Internal Medicine, 2012
- 5-Fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levelsMedical Oncology, 2009
- 5-fluorouracil cardiotoxicity is a rare, dose and schedule-dependent adverse event: a prospective study.2007
- Cardiotoxicity of 5-FluorouracilCardiovascular & Hematological Agents in Medicinal Chemistry, 2006
- [Cardiotoxicity of 5-fluorouracil].2004
- 5-Fluorouracil induces arterial vasocontractionsAnnals of Oncology, 2004
- In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle.1993
- Review: 5-Fluorouracil cardiotoxicity: A critical reviewAnnals of Oncology, 1990
- Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study.Journal of Clinical Oncology, 1989